QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Web of Science (11) Citing Articles via Google Scholar Google Scholar Articles by Smit, J. J. M. Articles by Borst, P. Search for Related Content PubMed PubMed Citation Articles by Smit, J. J. M. Articles by Borst, P.

 Previous Article  |  Next Article 

Volume 16, Number 20, Issue of October 15, 1996 pp. 6386-6393
Copyright ©1996 Society for Neuroscience

Peripheral Neuropathy in Mice Transgenic for a Human MDR3 P-Glycoprotein Mini-Gene

Jaap J. M. Smit¹, Frank Baas⁵, Jessica E. Hoogendijk³, Gerard H. Jansen⁴, Martin A. van der Valk², Alfred H. Schinkel¹, Anton J. M. Berns², Dennis Acton², Kees Nooter⁶, Herman Burger⁶, Sander J. Smith¹, and Piet Borst¹

¹ The Netherlands Cancer Institute, Divisions of Molecular Biology and ² Molecular Genetics, 1066 CX Amsterdam, The Netherlands, ³ University Hospital Utrecht, Departments of Neurology and ⁴ Pathology, Subdivision of Neuropathology, 3508 GA Utrecht, The Netherlands, ⁵ Department of Neurology, Academic Medical Center, 1105 AZ Amsterdam, The Netherlands, and ⁶ Department of Oncology, University Hospital Rotterdam, 3015 GD Rotterdam, The Netherlands

We have generated mice transgenic for a human MDR3 mini-gene, under control of a hamster vimentin promoter. Expression of the MDR3 transgene was found in mesenchymal tissues, peripheral nerves, and the eye lens. These MDR3 transgenic mice have a slowed motor nerve conduction and dysmyelination of their peripheral nerves. An extensive dysmyelination in some transgenic strains results in a severe peripheral neuropathy with paresis of the hind legs. How expression of the MDR3 transgene causes these abnormalities is unknown. The MDR3 gene encodes a large glycosylated plasma membrane protein with multiple transmembrane spanning domains, which are involved in the translocation of the phospholipid phosphatidylcholine through the hepatocyte canalicular membrane. The ability of the MDR3 P-glycoprotein to alter phospholipid distribution in the plasma membrane of Schwann cells may cause the damage. It is also possible, however, that the presence of a large glycoprotein in the cell membrane may be sufficient to severely disturb myelination of peripheral nerves.

Key words: peripheral neuropathy; dysmyelination; vimentin promoter; transgenic mice; MDR3; P-glycoprotein

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help